The invention relates to the technical field of
tumor biology, and particularly discloses a human malignant bone cytomegaloma
cell line and application thereof.The human malignant bone cytomegaloma
cell line is preserved on April 9, 2025, the preservation address is China Center for Type Culture Collection, the human malignant bone cytomegaloma
cell line is located in Wuhan University, Wuhan, Hubei province, and the preservation number is CCTCC NO: C202539. The human malignant bone cytomegaloma cell line disclosed by the invention comes from tumor tissues of a Chinese malignant bone cytomegaloma patient after operation excision, and is suitable for being used as a
cell material for research and development of malignant bone cytomegaloma related
immunotherapy, diagnosis and
medicine research and development. The cell line provided by the invention contains H3F3A G34W
mutation, and has high sensitivity and specificity in diagnosis of malignant bone cytomegaloma. The cell line can be used as a tool cell for targeted
drug research taking H3F3A as a target, a
cell model is provided for research of malignant bone cytomegaloma of Chinese people, and an experimental platform is also provided for mechanism research of malignant bone cytomegaloma.